EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Generative artificial intelligence for small molecule drug design

Ganesh Chandan Kanakala, Sriram Devata, Prathit Chatterjee, Udaykumar Deva Priyakumar

Current Opinion in Biotechnology · 2024

DOI: 10.1016/j.copbio.2024.103175 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Opinion in Biotechnology, 2024. Verfasst von Ganesh Chandan Kanakala und 3 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Computational Natural Sciences and Bioinformatics, International Institute of Information Technology, Hyderabad 500032, Telangana, India. Hauptthemen laut MEDLINE: Artificial Intelligence, Drug Design. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: Indraprastha Institute of Information Technology, Delhi, Department of Science and Technology, Ministry of Science and Technology, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In recent years, the rapid advancement of generative artificial intelligence (GenAI) has revolutionized the landscape of drug design, offering innovative solutions to potentially expedite the discovery of novel therapeutics. GenAI encompasses algorithms and models that autonomously create new data, including text, images, and molecules, often mirroring characteristics of existing datasets. This comprehensive review delves into the realm of GenAI for drug design, emphasizing recent advancements and methodologies that have propelled the field forward. Specifically, we focus on three prominent paradigms: transformers, diffusion models, and reinforcement learning algorithms, which have been exceptionally impactful in the last few years. By synthesizing insights from a myriad of studies and developments, we elucidate the potential of these approaches in accelerating the drug discovery process. Through a detailed analysis, we explore the current state and future directions of GenAI in the context of drug design, highlighting its transformative impact on pharmaceutical research and development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Artificial IntelligenceDrug DesignHumansAlgorithmsDrug DiscoverySmall Molecule Libraries

Substanzen

Small Molecule Libraries

Autor:innen und Institutionen

  • Centre for Computational Natural Sciences and Bioinformatics, International Institute of Information Technology, Hyderabad 500032, Telangana, India.
  • Centre for Computational Natural Sciences and Bioinformatics, International Institute of Information Technology, Hyderabad 500032, Telangana, India. Electronic address: deva@iiit.ac.in.

Förderung

  • Indraprastha Institute of Information Technology, Delhi
  • Department of Science and Technology, Ministry of Science and Technology, India

Zitieren

APA

Kanakala, G. C., Devata, S., Chatterjee, P., & Priyakumar, U. D. (2024). Generative artificial intelligence for small molecule drug design. Current Opinion in Biotechnology. https://doi.org/10.1016/j.copbio.2024.103175

Vancouver

Kanakala GC, Devata S, Chatterjee P, Priyakumar UD. Generative artificial intelligence for small molecule drug design. Current Opinion in Biotechnology. 2024. doi:10.1016/j.copbio.2024.103175

BibTeX
@article{Kanakala2024,
  author = {Kanakala, Ganesh Chandan and Devata, Sriram and Chatterjee, Prathit and Priyakumar, Udaykumar Deva},
  title = {Generative artificial intelligence for small molecule drug design},
  journal = {Current Opinion in Biotechnology},
  year = {2024},
  doi = {10.1016/j.copbio.2024.103175}
}
Kostenlos starten →